𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson’s disease

✍ Scribed by Z.H Wang; Y Ji; W Shan; B Zeng; N Raksadawan; G.M Pastores; T Wisniewski; E.H Kolodny

Book ID
117490570
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
628 KB
Volume
113
Category
Article
ISSN
0306-4522

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous glial-derived neurotrophic f
Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter
✍ Chun-Fang Xia; Ruben J. Boado; Yun Zhang; Chun Chu; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract ## Background Rats with experimental Parkinson's disease (PD) are treated with intravenous glial‐derived neurotrophic factor (GDNF) plasmid DNA, non‐viral gene therapy using Trojan horse liposomes (THLs) targeted with a monoclonal antibody (MAb) to the rat transferrin receptor (TfR). E

NMDA receptors mediate an early up-regul
NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease
✍ Gonzalo Bustos; Jorge Abarca; Victor Bustos; Eduardo Riquelme; Viviana Noriega; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 1 views

## Abstract The clinical symptoms of Parkinson's disease (PD) appear late and only when the degenerative process at the level of the nigrostriatal dopamine (DA) pathway is quite advanced. An increase in brain‐derived neurotrophic factor (BDNF) expression may be one of the molecular signals associat